InvestorsHub Logo

TPX

Followers 0
Posts 40567
Boards Moderated 4
Alias Born 10/24/2013

TPX

Re: None

Friday, 10/13/2017 11:38:10 AM

Friday, October 13, 2017 11:38:10 AM

Post# of 50649
Global Fatigue Therapeutics Report, H1 2017: Pipeline Review of the Top Drugs Companies & Molecules – Research and Markets

OCTOBER 13, 2017

Fatigue Market Pipeline Review, H1 2017, latest research study provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics. Fatigue therapeutics industry report provides comprehensive information on the therapeutics under development for Fatigue, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Fatigue Market and features dormant and discontinued projects.

Leading Key players in Fatigue Market– Pipeline Review, H1 2017 areAoxing Pharmaceutical Company Inc, BioLite Inc, Biovista Inc, Chronos Therapeutics Ltd, Grifols SA, Hemispherx Biopharma Inc, K-Pax Pharmaceuticals Inc, Merz Pharma GmbH & Co KgaA, MultiCell Technologies Inc and Others.

http://www.satprnews.com/2017/10/13/global-fatigue-therapeutics-report-h1-2017-pipeline-review-of-the-top-drugs-companies-molecules-research-and-markets/